CARLSBAD, Calif. (AP) _ GenMark Diagnostics Inc. (GNMK) on Wednesday reported a loss of $3.2 million in its third quarter.

The Carlsbad, California-based company said it had a loss of 5 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share.

The molecular diagnostics company posted revenue of $42.6 million in the period.

GenMark Diagnostics shares have more than doubled since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $11.58, a rise of 95% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GNMK at https://www.zacks.com/ap/GNMK

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News